Company / Operating Cash Flow
PAVmed Inc. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$33.6M
FY2025
5-year range
-$71.0M / -$21.9M
FY2021-FY2025
Trend
+35.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$71M to -$34M over the past 2 years.
Based on SEC 10-K filings.
-$34M in FY2025.
Improved from -$71M to -$34M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 35.5% year-over-year.
- Peak operating cash flow was recorded in FY2021.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$33.6M | +35.5% |
| FY2024 | -$52.0M | +26.7% |
| FY2023 | -$71.0M | -74.9% |
| FY2022 | -$40.6M | -85.2% |
| FY2021 | -$21.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026